Suppr超能文献

格列齐特-聚乙二醇固体分散体的理化性质表征及基于优化分散体的片剂

Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, Safat, Kuwait.

出版信息

Drug Dev Ind Pharm. 2010 Aug;36(8):893-902. doi: 10.3109/03639040903578734.

Abstract

BACKGROUND

This study investigated the physical interaction of gliclazide (GLC) with a hydrophilic carrier, that is, macrogol [polyethylene glycol (PEG)]. Different molecular weights of PEG (4000, 10,000, and 20,000) were used in different drug : carrier weight ratios (1 : 1, 1 : 2, 1 : 5, and 1 : 10).

METHOD

Preliminary screening was done by phase solubility studies to characterize the liquid state interaction between the drug and the carrier. Solid dispersions (SDs) of GLC and PEG in different ratios were prepared by fusion technique and by physical mixing. The solid-state interaction between the drug and the carrier was examined by performing differential scanning calorimetry and Fourier transform infrared spectroscopic studies. SD with satisfactory characteristics was selected for the formulation of tablets by wet granulation method and compared with the commercial brand for in vitro dissolution.

RESULTS

It was evident from phase solubility studies that the drug solubility increased linearly with increasing PEG concentrations. In vitro dissolution of GLC improved significantly in the SDs prepared by fusion method as compared with the original drug and physical mixtures. Scanning electron microscopy images showed well-defined changes in the surface topography of GLC, thus confirming the effective formation of a fused binary system. The SD tablets showed a significant improvement in the drug release profile than that of the commercial brand.

CONCLUSION

It was thus concluded that SD formulations of GLC can be successfully used to design a solid dosage form of the drug, which would have significant advantages over the current marketed tablets.

摘要

背景

本研究调查了格列齐特(GLC)与亲水性载体,即聚乙二醇(PEG)的物理相互作用。不同分子量的 PEG(4000、10000 和 20000)以不同的药物:载体重量比(1:1、1:2、1:5 和 1:10)用于研究。

方法

通过相溶解度研究进行初步筛选,以表征药物与载体之间的液态相互作用。通过熔融技术和物理混合制备 GLC 和 PEG 以不同比例的固体分散体(SD)。通过差示扫描量热法和傅里叶变换红外光谱研究检查药物与载体之间的固态相互作用。选择具有满意特性的 SD 通过湿法制粒法制备片剂,并与市售品牌进行体外溶出度比较。

结果

相溶解度研究表明,药物溶解度随 PEG 浓度的增加呈线性增加。与原药和物理混合物相比,熔融法制备的 SD 中 GLC 的体外溶出度显著提高。扫描电子显微镜图像显示 GLC 的表面形貌发生了明显变化,从而证实了熔融二元体系的有效形成。SD 片剂的药物释放曲线明显优于市售品牌。

结论

因此,可以得出结论,GLC 的 SD 制剂可成功用于设计该药物的固体制剂,这将比当前市售片剂具有显著优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验